Skip to content

BRUPHARMEXPORT

Inactive KBO/BCE: BE 0424.139.428

Curator

1 mandate
Curator, Rue Omer Lefevre 36, 7100 La Louviere
from 19-07-2022 to 29-01-2024
Also on 126 other cases

Mandates through the years

4 names, the dashed line is today
Earliermandate already running before its first mentionend not datedBankruptcy 19-07-2022
Mandates as a list
  • Olivier Charles Guy Vandecauter
    • Director, appointed by deed of 13-03-2020, until 29-07-2020
  • VANDECAUTER Eric Christian Charles Jean Franz
    • Director (not named in the articles), appointed by deed of 12-08-2019, until 03-03-2020
    • Manager, until 12-08-2019
    • Director, appointed by deed of 29-07-2020, last mentioned in 2020
  • Edouard Henderyckx
    • Manager, until 16-04-2018
  • Eric Vandecauter
    • Manager, appointed by deed of 16-04-2018, last mentioned in 2018

Control

Shareholders
VANDECAUTER Eric Christian Charles Jean Franz, DOLHEN Agnès Marthe Blanche
This company
BRUPHARMEXPORT
Equity -€1.7m
Profit €38,563 in 2021

Capital

Capital
€422,000
Shares
17,023
Contribution per share
€24.79
Equity per share
-€98.43 in 2021
Source
deed of 12-08-2019

Articles of association

deed of 12-08-2019 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant,moitié acquéreurs proportionnellement si plusieurs, tenus de solliciter agrément selon mêmes formalités sauf ayants droit de…”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Tuesday of May at 11:00

Shareholders

After the capital increase deed of 12-08-2019 ↗
  • DOLHEN Agnès Marthe Blanche 4,023 shares · €99,738.42 in cash
Stated in the deed deed of 12-08-2019 ↗

Capital transactions

Capital over time
  1. 12-08-2019 Capital increase of €99,738.42 · to €422,000 · 4,023 new shares at €24.79 per share, 23.6% of the 17,023 shares after the increase
  2. 12-08-2019 Converted to unavailable equity · €422,000

Office holders in the KBO →

Next steps